14.9 C
Wednesday, May 12, 2021


A technician demonstrates the process of transferring cell samples into a vial at the Gracell Biotechnology Ltd. research laboratory in Shanghai, China, on Tuesday, Oct. 29, 2019. Chinese startup Gracell is trialing Chimeric Antigen Receptor-T cells, known as CAR-T, and the gene therapy is being hailed as one of the most exciting developments in the quest to cure cancer. CAR-T re-works the genes of the body’s own immune cells so that they actively seek out and destroy cancer cells. While its been embraced by researchers and drugmakers around the world, perhaps nowhere is CAR-T having more impact than in China, home to the world’s biggest cancer population and some of the most ambitious experiments. Photographer: Qilai Shen/Bloomberg via Getty Images